Aetna Sees 80% Decrease In Rx Non-Sedating Antihistamine Use Post-Claritin
Executive Summary
Aetna's aggressive formulary management steps following the OTC switch of Claritin have led to an 80% decrease in use of prescription non-sedating antihistamines by members, the insurer says
You may also be interested in...
Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition
WellPoint will not take legal action against FDA should the agency reject the health insurer's citizen petition to force an OTC switch of prescription low- and non-sedating antihistamines
Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition
WellPoint will not take legal action against FDA should the agency reject the health insurer's citizen petition to force an OTC switch of prescription low- and non-sedating antihistamines
Allegra Hurt By Stocking, Late Allergy Season, Not Other Products – Aventis
Aventis expects its allergy therapy Allegra to achieve single-digit growth in 2003 despite a slow first quarter, the company told analysts April 30